scholarly article | Q13442814 |
meta-analysis | Q815382 |
P2093 | author name string | Szajewska H | |
Skórka A | |||
Dylag M | |||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea | Q34017677 | ||
Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice | Q50137792 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Saccharomyces boulardii | Q135368 |
diarrhea | Q40878 | ||
meta-analysis | Q815382 | ||
P304 | page(s) | 257-264 | |
P577 | publication date | 2007-02-01 | |
P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
P1476 | title | Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children | |
P478 | volume | 25 |
Q26771884 | A gastrointestinal anti-infectious biotherapeutic agent: the heat-treated Lactobacillus LB |
Q37332138 | Acute infectious diarrhea in children |
Q37762543 | An update on management of severe acute infectious gastroenteritis in children. |
Q37976693 | Beneficial effects of probiotic and food borne yeasts on human health |
Q35185460 | Chloride secretion induced by rotavirus is oxidative stress-dependent and inhibited by Saccharomyces boulardii in human enterocytes |
Q33693688 | Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study |
Q28294880 | Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection |
Q36327809 | Comparison of Two Forms of Loperamide-Simeticone and a Probiotic Yeast (Saccharomyces boulardii) in the Treatment of Acute Diarrhoea in Adults: A Randomised Non-Inferiority Clinical Trial |
Q34159275 | Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea |
Q43349027 | Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial |
Q33877152 | Effects of consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114 001 on common respiratory and gastrointestinal infections in shift workers in a randomized controlled trial |
Q37994188 | Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders |
Q36014797 | Fermented Milk Consumption and Common Infections in Children Attending Day-Care Centers: A Randomized Trial |
Q84595951 | Gastroenteritis in children |
Q36415190 | Gastrointestinal microbiota and some children diseases: a review |
Q34089565 | Guidelines on acute gastroenteritis in children: a critical appraisal of their quality and applicability in primary care |
Q37969593 | Indications for the use of probiotics in gastrointestinal diseases |
Q36278070 | Infant fungal communities: current knowledge and research opportunities |
Q40199926 | Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. |
Q27004496 | Management strategies in the treatment of neonatal and pediatric gastroenteritis |
Q46930970 | Medication in infectious acute diarrhea in children |
Q39281119 | Microbiota and probiotics: effects on human health |
Q35812927 | New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics |
Q42502726 | Oral administration of Saccharomyces boulardii alters duodenal morphology, enzymatic activity and cytokine production response in broiler chickens |
Q33668674 | Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial |
Q37568157 | Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. |
Q36567134 | Probiotics and the gut microbiota in intestinal health and disease |
Q24236704 | Probiotics for treating acute infectious diarrhoea |
Q34646254 | Probiotics in infectious diarrhoea in children: are they indicated? |
Q33438518 | Probiotics in the management of colonic disorders |
Q53666076 | Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea. |
Q42871284 | Recent advances in Saccharomyces boulardii research |
Q34411373 | Recommendations for probiotic use in humans-a 2014 update |
Q34494363 | Review article: the management of acute gastroenteritis in children. |
Q43223298 | Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children. |
Q37355090 | Saccharomyces boulardii in childhood |
Q90459802 | Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review |
Q46410417 | Selenium fortification of infant formulas: does selenium form matter? |
Q34624014 | The clinical importance of intestinal microbiota |
Q41677313 | The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study |
Q92993814 | The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clin |
Q37424366 | The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea |
Q38174603 | The role of probiotics and prebiotics in inducing gut immunity. |
Q37710786 | Treating irritable bowel syndrome with probiotics: the evidence |
Q34359324 | Treatment of acute gastroenteritis in children: an overview of systematic reviews of interventions commonly used in developed countries |
Q37182888 | Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives |
Q37216850 | What is the evidence for the use of probiotics in functional disorders? |
Q50860172 | Yeasts from kefir grains: isolation, identification, and probiotic characterization. |
Search more.